Participants 194 348 6
out-patients suffering from moderate to severe depression were treated with the objective of assessing the new drug's therapeutically effective dose range
Participants 392 509 3
fourteen patients were assigned to receive diclofensine and thirteen to receive maprotiline in a double-blind design.
Participants 1208 1283 3
patients in whom a psycho-energizing and mood alleviating effect is desired
